万维读者网>世界军事论坛>帖子
10/16 Coronavirus Live Updates:
送交者: logic. 2020-10-16 19:10:15 于 [世界军事论坛]

Coronavirus live updates: New cases are up in 39 states; Pfizer targets November for vaccine emergency use

This is CNBC’s live blog covering all the latest news on the coronavirus outbreak. This blog will be updated throughout the day as the news breaks. 

Daily new U.S. cases of the coronavirus, as a seven-day average, have been growing since Oct. 5 and topped 53,405 as of Thursday, according to a CNBC analysis of Johns Hopkins data. Average daily new infections are 14% higher than a week ago, CNBC’s analysis shows. The European Central Bank is prepared to impose further economic stimulus amid an upsurge of cases in Europe. Yet, negotiations of a U.S. stimulus deal have been deadlocked for weeks.

Here are some of the biggest developments on Friday:

Chart showing daily new coronavirus cases per capita in the U.S. and Europe.

The following data was compiled by Johns Hopkins University:

  • Global cases: More than 38.9 million

  • Global deaths: At least 1.09 million

  • U.S. cases: More than 7.98 million

  • U.S. deaths: At least 217,717

In open letter, Pfizer CEO vows ‘high’ safety standards for vaccine

Albert Bourla, Pfizer
Albert Bourla, Pfizer
Gian Ehrenzeller | Keystone | AP

Pfizer CEO Albert Bourla said the pharmaceutical company’s safety standards for its potential coronavirus vaccine are “set high” as it approaches a regulatory filing with the Food and Drug Administration.

Shares of Pfizer were up nearly 2% in mid-morning trading after Bourla said in an open letter that the company would not apply for emergency use authorization for its Covid-19 vaccine until late November as it continues to gather crucial safety data.

“Safety is, and will remain, our number one priority, and we will continue monitoring and reporting safety data for all trial participants for two years,” he wrote.

The letter comes amid concerns about the safety of potential Covid-19 vaccines or treatments. Coronavirus clinical trials from drug giants Johnson & Johnson and Eli Lilly hit a snag this week after independent safety monitors halted them over bad reactions from participants. –Berkeley Lovelace Jr.

New cases are up in 39 states

Average daily new cases of the coronavirus were up by at least 5% on a weekly basis in 39 states on Thursday, according to a CNBC analysis of data compiled by Johns Hopkins University.

Cases are rising most rapidly in Michigan, Nebraska and South Dakota, according to CNBC’s analysis. Adjusted for population, the Dakotas, Montana, Wisconsin and Utah reported more new cases on Thursday than any other state, according to the analysis.

Chart showing daily new coronavirus cases per capita by U.S. state.

Daily new cases reported across the country are rapidly approaching fresh record levels. The U.S. reported more than 63,600 new cases on Thursday, pushing the seven-day average of daily new cases over 53,400, up more than 13% compared with a week ago.

“I’m pretty glum at the moment because it does look as though in the majority of states there’s an increasing number of cases,” Dr. Bill Schaffner, an epidemiologist at Vanderbilt University, said. “There’s a growing sense of coronavirus fatigue out there. People really want to get back to the old normal.” —Will Feuer

WHO finds Remdesivir has ‘little or no effect’ in reducing deaths

Interim results of a study coordinated by the World Health Organization indicated that Gilead Sciences’ remdesivir, along with three other potential coronavirus treatment drugs, had “little or no effect” on death rates among hospitalized patients.

The WHO’s randomized Solidarity Therapeutics Trial was conducted on 11,266 patients, with 2,750 given remdesivir, across 30 countries. It comes a week after Gilead published its own study on remdesivir.

The authors of the WHO study said: “No study drug definitely reduced mortality (in unventilated patients or any other subgroup of entry characteristics), initiation of ventilation or hospitalisation duration.” —Vicky McKeever

Latest hot spots of new U.S. cases

national

Indianapolis Colts close practice facility after positive tests reported

The Indianapolis Colts closed its practice facility after the National Football League team learned several people within its organization tested positive for Covid-19.

The Colts will work remotely and the team is currently in the process of confirming those tests, according to a statement on its website. —Melodie Warner 

Gottlieb says Trump should promote responsible mask use

VIDEO01:43
Trump should promote responsible mask use, says former FDA chief Scott Gottlieb

Disclosure: Dr. Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic-testing start-up Tempus and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings′ and Royal Caribbean’s “Healthy Sail Panel.”

Pfizer targets late-November filing for vaccine’s emergency use approval

In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.
In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.
University of Maryland School of Medicine | AP

Pfizer is targeting late-November to apply for emergency use approval of its Covid-19 vaccine in the U.S., Reuters reports.

Pfizer is developing its vaccine candidate with Germany’s BioNTech and estimated a key safety milestone would be achieved in the third week of November.

That would be the first emergency use approval request for a Covid-19 vaccine, though several coronavirus treatments have already gone through the process. President Donald Trump has repeatedly touted a November timeline for a vaccine while providing few specifics. —Sara Salinas

Read CNBC’s previous live coverage here:


0.00%(0) 0.00%(0) 0.00%(0)
当前新闻共有0条评论
笔  名 (必选项):
密  码 (必选项):
注册新用户
标  题 (必选项):
内  容 (选填项):